Female Health ROE 2006-2019 | VERU

Current and historical return on equity (ROE) values for Female Health (VERU) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Female Health ROE for the three months ending June 30, 2019 was -50.14%.
Female Health ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2019-06-30 $-0.02B $0.04B -50.37%
2019-03-31 $-0.02B $0.03B -64.71%
2018-12-31 $-0.02B $0.04B -61.54%
2018-09-30 $-0.02B $0.03B -63.58%
2018-06-30 $-0.02B $0.04B -49.41%
2018-03-31 $-0.01B $0.04B -30.27%
2017-12-31 $-0.01B $0.05B -24.49%
2017-09-30 $-0.01B $0.05B -17.65%
2017-06-30 $-0.01B $0.05B -12.63%
2017-03-31 $-0.00B $0.05B -9.14%
2016-12-31 $-0.00B $0.05B -5.06%
2016-09-30 $0.00B $0.03B 0.00%
2016-06-30 $0.00B $0.04B 8.63%
2016-03-31 $0.00B $0.04B 8.89%
2015-12-31 $0.01B $0.04B 15.27%
2015-09-30 $0.01B $0.03B 16.00%
2015-06-30 $0.00B $0.03B 10.00%
2015-03-31 $0.00B $0.03B 10.26%
2014-12-31 $0.00B $0.03B 3.51%
2014-09-30 $0.00B $0.03B 3.51%
2014-06-30 $0.01B $0.03B 30.77%
2014-03-31 $0.01B $0.03B 31.30%
2013-12-31 $0.01B $0.03B 42.48%
2013-09-30 $0.02B $0.03B 55.56%
2013-06-30 $0.02B $0.03B 63.37%
2013-03-31 $0.02B $0.03B 76.60%
2012-12-31 $0.02B $0.02B 80.00%
2012-09-30 $0.02B $0.02B 82.05%
2012-06-30 $0.01B $0.02B 73.24%
2012-03-31 $0.01B $0.02B 62.50%
2011-12-31 $0.01B $0.02B 52.46%
2011-09-30 $0.01B $0.02B 33.90%
2011-06-30 $0.01B $0.01B 41.38%
2011-03-31 $0.01B $0.01B 42.11%
2010-12-31 $0.01B $0.02B 58.18%
2010-09-30 $0.01B $0.02B 53.85%
2010-06-30 $0.00B $0.01B 24.49%
2010-03-31 $0.00B $0.01B 33.33%
2009-12-31 $0.00B $0.01B 34.78%
2009-09-30 $0.01B $0.01B 65.12%
2009-06-30 $0.01B $0.01B 70.00%
2009-03-31 $0.01B $0.01B 73.68%
2008-12-31 $0.01B $0.01B 64.86%
2008-09-30 $0.01B $0.01B 55.56%
2008-06-30 $0.00B $0.01B 48.48%
2008-03-31 $0.00B $0.01B 40.00%
2007-12-31 $0.00B $0.01B 29.63%
2007-09-30 $0.00B $0.01B 16.67%
2007-06-30 $0.00B $0.01B 0.00%
2007-03-31 $0.00B $0.01B 0.00%
2006-12-31 $0.00B $0.01B 0.00%
2006-09-30 $0.00B $0.01B 0.00%
2006-06-30 $0.00B $0.00B 0.00%
2006-03-31 $0.00B $0.00B 0.00%
2005-12-31 $0.00B $0.00B 0.00%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.125B $0.016B
Veru Inc. engages in the development, manufacture and marketing of consumer health care products. It focuses on producing FC2 female condom which provides dual protection against unintended pregnancy and sexually transmitted infections. Veru Inc., formerly known as The Female Health Company, is headquartered in Miami, FL.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $150.600B 28.31
Medtronic (MDT) Ireland $148.093B 20.79
Stryker (SYK) United States $82.318B 28.47
Boston Scientific (BSX) United States $58.839B 28.54
Baxter (BAX) United States $44.837B 27.19
EssilorLuxottica Societe Anonyme (ESLOY) France $31.126B 0.00
Zimmer Biomet Holdings (ZBH) United States $29.280B 18.74
Lonza Group Ag (LZAGY) Switzerland $25.580B 0.00
Coloplast (CLPBY) Denmark $25.337B 40.45
Terumo (TRUMY) Japan $21.867B 25.14
Smith & Nephew SNATS (SNN) United Kingdom $20.565B 0.00
ResMed (RMD) United States $19.246B 36.70
Sunny Optical Technology (SNPTF) China $16.233B 0.00
Bio-Rad Laboratories (BIO) United States $10.009B 53.66
Canopy Growth (CGC) Canada $9.229B 0.00
Insulet (PODD) United States $8.710B 516.14
Perrigo (PRGO) Ireland $7.614B 14.02
William Demant Holdings (WILYY) Denmark $7.386B 0.00
Hill-Rom Holdings (HRC) United States $7.067B 21.07
Haemonetics (HAE) United States $6.391B 48.23
Aurora Cannabis (ACB) Canada $6.010B 0.00
GN STORE NORD (GNNDY) Denmark $5.608B 28.98
GW Pharmaceuticals (GWPH) United Kingdom $4.399B 0.00
Shandong Weigao Medical Polymer (SHWGF) China $4.296B 0.00
Neogen (NEOG) United States $4.046B 67.17
NuVasive (NUVA) United States $3.422B 27.28
ICU Medical (ICUI) United States $3.306B 21.44
Hutchison China MediTech (HCM) China $2.938B 0.00
Quidel (QDEL) United States $2.835B 28.16
National Vision Holdings (EYE) United States $2.466B 53.22
Agios Pharmaceuticals (AGIO) United States $2.241B 0.00
Cardiovascular Systems (CSII) United States $1.803B 0.00
Aphria (APHA) $1.669B 0.00
VAREX IMAGING (VREX) United States $1.137B 26.19
AtriCure (ATRC) United States $0.971B 0.00
Lantheus Holdings (LNTH) United States $0.933B 24.52
Omeros (OMER) United States $0.898B 0.00
Phibro Animal Health (PAHC) United States $0.848B 13.79
Eagle Pharmaceuticals (EGRX) United States $0.809B 20.62
NanoString Technologies (NSTG) United States $0.779B 0.00
PetIQ (PETQ) United States $0.762B 18.01
Cerus (CERS) United States $0.739B 0.00
LeMaitre Vascular (LMAT) United States $0.692B 41.03
MacroGenics (MGNX) United States $0.664B 0.00
Quanterix (QTRX) United States $0.664B 0.00
TG Therapeutics (TGTX) United States $0.644B 0.00
Surmodics (SRDX) United States $0.629B 119.64
OraSure Technologies (OSUR) United States $0.469B 21.70
Owens & Minor (OMI) United States $0.447B 13.40
Meridian Bioscience (VIVO) United States $0.419B 13.09
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.414B 0.00
BioLife Solutions (BLFS) United States $0.372B 122.19
Utah Medical Products (UTMD) United States $0.371B 27.16
United Health Products (UEEC) United States $0.323B 0.00
Zynex (ZYXI) United States $0.278B 29.52
Bovie Medical (APYX) United States $0.255B 0.00
Rockwell Medical (RMTI) United States $0.186B 0.00
Cytosorbents (CTSO) United States $0.172B 0.00
Vapotherm (VAPO) United States $0.165B 0.00
Fonar (FONR) United States $0.151B 7.96
Chimerix (CMRX) United States $0.134B 0.00
Chembio Diagnostics (CEMI) United States $0.113B 0.00
United-Guardian (UG) United States $0.089B 21.05
Surface Oncology (SURF) United States $0.058B 0.00
Nephros (NEPH) United States $0.057B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.052B 0.00
ImmuCell (ICCC) United States $0.039B 0.00
Trinity Biotech (TRIB) Ireland $0.029B 0.00
Senestech (SNES) United States $0.027B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.012B 0.00
Capricor Therapeutics (CAPR) United States $0.010B 0.00
GUARDION HEALTH (GHSI) United States $0.010B 0.00
Valeritas Holdings (VLRX) United States $0.010B 0.00
Akers Biosciences Inc (AKER) United States $0.006B 0.00
NeuroMetrix (NURO) United States $0.004B 0.00